Immediate Impact
30 standout
Citing Papers
Therapeutic advances in rheumatoid arthritis
2024 Standout
Rheumatoid arthritis: pathogenesis and therapeutic advances
2024 Standout
Works of Meryem Can being referenced
Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Meryem Can | 262 | 81 | 87 | 109 | 105 | 34 | 427 | |
| Francesca Ometto | 283 | 66 | 36 | 127 | 100 | 28 | 495 | |
| L. Zakraoui | 229 | 56 | 64 | 88 | 79 | 57 | 409 | |
| S-K Kwok | 327 | 32 | 57 | 207 | 47 | 22 | 490 | |
| Hyun Kyu Chang | 230 | 136 | 31 | 30 | 58 | 23 | 388 | |
| Berivan Bıtık | 182 | 66 | 37 | 78 | 63 | 36 | 438 | |
| Mira Merashli | 311 | 87 | 59 | 95 | 135 | 41 | 482 | |
| Camelia Doina Vrabie | 263 | 58 | 40 | 116 | 52 | 27 | 489 | |
| Eduardo Martín‐Nares | 218 | 81 | 50 | 51 | 34 | 40 | 491 | |
| Raquel Faria | 224 | 41 | 58 | 120 | 82 | 31 | 407 | |
| Carlos Marras | 210 | 41 | 17 | 35 | 77 | 27 | 414 |
All Works
Login with ORCID to disown or claim papers
Loading papers...